Very Early PSA Response to Abiraterone in mCRPC Patients: A Novel Prognostic Factor Predicting Overall Survival

Overview of attention for article published in Frontiers in Pharmacology, May 2016

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 5,774 followers.

Very Early PSA Response to Abiraterone in mCRPC Patients: A Novel Prognostic Factor Predicting Overall Surviv... https://t.co/e6KkDVe4bT

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.